Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models (Q46829192)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 November 2005

Language	Label	Description	Also known as
English	Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models	scientific article published on 30 November 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

author name string

Sridhar Natesan

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

Greg E Reckless

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

José N Nobrega

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

Paul J Fletcher

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

language of work or name

0 references

publication date

30 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

31

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

1854-1863

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

21 January 2018

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

21 January 2018

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

21 January 2018

The role of serotonin in antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

21 January 2018

Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Inverse agonist properties of atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of classical and novel antipsychotics using animal models.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of olanzapine on regional C-Fos expression in rat forebrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial dopamine agonists in the treatment of psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300983

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300983

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16319908

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46829192&oldid=2208158478"